Biomax Provides AI-Based Semantic Search Platform AILANI and Supports COVID-19 International Efforts

Biomax InformaticsThe bioinformatics company Biomax, headquartered in Planegg, Germany, makesitssemantic search platform AILANI available free of charge to research institutes around the world in order to support the rapid and successful search for drugs and suitable vaccinesagainst COVID-19 infections.

Biomax experts have pre-configured AILANI forthe specific needs of researchers in the field of COVID-19 and integrated publicly available literature, data and knowledge.Using AILANI scientists get faster insight in existing knowledge, discover previously unknown associationsand areable to takebetter research decisions.The new search platform is accessible at https://ailani.ai.

Biomax also supports international efforts to collect knowledge with a special text mining system. In this context Biomaxispartner of PREPARE, a platform for European Preparedness against (Re-)Emerging Epidemics,and member of the COVID-19 Disease Map Community, a European program that has beenset up to share resources and best practices to develop a disease map for COVID-19andSARS-CoV-2.

Biomax's expertise in electronic case reporting (eCRF) and the established data integration system BioXM additionally enables the design of an open, comprehensive information network for the collection, management and analysis of data on the COVID-19 epidemic, clinical disease progression or rehabilitation, tohelp physicians find the best treatment for their individual patients.

For further information, please visit:
http://www.biomax.com

About Biomax Informatics

Biomax Informatics provides services and software solutions for efficient decision making and knowledge management at the intersection of life sciences, healthcare and information technologies. Biomax facilitates digital transformation within biotech, pharma,agriculture, food and chemical industries as well as research institutes.

The companylooks back on 20 years of experience and currently employs around 50 people - including numerous life scientists, data scientists and software developers with a scientific background.

Founded in 1997, Biomax Informatics is ISO9001 and ISO27001 certified and is headquartered in Planegg near Munich, Germany.

Most Popular Now

First Virtual DMEA to Open with a Wide R…

16 - 18 June 2020, Berlin, Germany. Under the heading 'DMEA sparks' and taking place for the first time, this year's DMEA is an entirely virtual event. From 16 to 18...

Philips Launches HealthSuite Clinical Tr…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, announced Clinical Trial Accelerator on Philips HealthSuite. This new tailored set of capabilities allows life science organizations to...

New AI Diagnostic can Predict COVID-19 w…

Researchers at King's College London, Massachusetts General Hospital and health science company ZOE have developed an artificial intelligence diagnostic that can predict whether someone is likely to have COVID-19 based...

Biomax Provides AI-Based Semantic Search…

The bioinformatics company Biomax, headquartered in Planegg, Germany, makesitssemantic search platform AILANI available free of charge to research institutes around the world in order to support the rapid and successful...

COVID-19 and Health Tech: Building on th…

Highland Marketing's advisory board met to discuss the health tech response to the coronavirus outbreak. In many areas, this has been hugely impressive: but there are gaps, and there will...

InsurTech Hub Munich and dmac/Digital He…

InsurTech Hub Munich (ITHM) and dmac - Medical Valley Digital Health Application Center part of the Digital Health Hub Nuremberg/Erlangen announce a new cross-industry accelerator for the second half of...

Viveo Health Offers Free Telemedicine So…

Viveo Health, a global e-Health innovator, is making its 'Virtual Office for Doctors' platform free of charge to doctors and other medical professionals worldwide in light of the surge in...

The Dedalus Group, Participated by Ardia…

The Dedalus Group, a leading European company, and one of the worldwide main ones, active in clinical healthcare information systems to support clinical professionals and organizations in order to improve...

Supercomputer Simulations Present Potent…

Several drugs approved for treating hepatitis C viral infection were identified as potential candidates against COVID-19, a new disease caused by the SARS-CoV-2 coronavirus. This is the result of research...

The COVID-19 pandemic reveals the potent…

Two new articles provide insights on the use of telehealth or virtual care in the age of COVID-19 and beyond, pointing to its value to not only prevent contagious diseases...

WiFi SPARK Works with Visionable to Conn…

Seven NHS Trusts are using technology developed by WiFi SPARK in response to an urgent request from leading NHS Trusts to find a way to connect hospital patients with their...

Digital Contact Tracing for COVID-19: An…

An article in CMAJ (Canadian Medical Association Journal) analyzes the strengths and limitations of digital contact tracing for people infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to help...